These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 24628498

  • 1. Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting.
    Dolberg O, Larsson Lönn S, Kvist K.
    Curr Med Res Opin; 2014 Jul; 30(7):1301-7. PubMed ID: 24628498
    [Abstract] [Full Text] [Related]

  • 2. Escitalopram continuation treatment prevents relapse of depressive episodes.
    Rapaport MH, Bose A, Zheng H.
    J Clin Psychiatry; 2004 Jan; 65(1):44-9. PubMed ID: 14744167
    [Abstract] [Full Text] [Related]

  • 3. Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.
    Wade AG, Fernández JL, François C, Hansen K, Danchenko N, Despiegel N.
    Pharmacoeconomics; 2008 Jan; 26(11):969-81. PubMed ID: 18850765
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [Abstract] [Full Text] [Related]

  • 5. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
    Khan A, Bose A, Alexopoulos GS, Gommoll C, Li D, Gandhi C.
    Clin Drug Investig; 2007 Nov; 27(7):481-92. PubMed ID: 17563128
    [Abstract] [Full Text] [Related]

  • 6. Relapse prevention and residual symptoms: a closer analysis of placebo-controlled continuation studies with escitalopram in major depressive disorder, generalized anxiety disorder, social anxiety disorder, and obsessive-compulsive disorder.
    Bech P, Lönn SL, Overø KF.
    J Clin Psychiatry; 2010 Feb; 71(2):121-9. PubMed ID: 19961809
    [Abstract] [Full Text] [Related]

  • 7. Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder.
    Lepola U, Wade A, Andersen HF.
    Int Clin Psychopharmacol; 2004 May; 19(3):149-55. PubMed ID: 15107657
    [Abstract] [Full Text] [Related]

  • 8. Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder.
    Moore N, Verdoux H, Fantino B.
    Int Clin Psychopharmacol; 2005 May; 20(3):131-7. PubMed ID: 15812262
    [Abstract] [Full Text] [Related]

  • 9. A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder.
    Wade A, Gembert K, Florea I.
    Curr Med Res Opin; 2007 Jul; 23(7):1605-14. PubMed ID: 17559755
    [Abstract] [Full Text] [Related]

  • 10. A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder.
    Colonna L, Andersen HF, Reines EH.
    Curr Med Res Opin; 2005 Oct; 21(10):1659-68. PubMed ID: 16238906
    [Abstract] [Full Text] [Related]

  • 11. Escitalopram prevents relapse in older patients with major depressive disorder.
    Gorwood P, Weiller E, Lemming O, Katona C.
    Am J Geriatr Psychiatry; 2007 Jul; 15(7):581-93. PubMed ID: 17586783
    [Abstract] [Full Text] [Related]

  • 12. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
    Favré P.
    Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
    Hu YD, Xiang YT, Fang JX, Zu S, Sha S, Shi H, Ungvari GS, Correll CU, Chiu HF, Xue Y, Tian TF, Wu AS, Ma X, Wang G.
    Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA, Prakash A, Arnold LM, Aaronson ST, Mallinckrodt CH, Wohlreich MM.
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of Tianeptine 25-50 mg in Elderly Patients With Recurrent Major Depressive Disorder: An 8-Week Placebo- and Escitalopram-Controlled Study.
    Emsley R, Ahokas A, Suarez A, Marinescu D, Dóci I, Lehtmets A, Milanova V, Lee MS, Didi R, Araszkiewicz A, Sulaiman AH, Blanchot FP, Crutel VS, Antoine C, Penelaud PF.
    J Clin Psychiatry; 2018 Jul 03; 79(4):. PubMed ID: 29995359
    [Abstract] [Full Text] [Related]

  • 19. Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD).
    Wade AG, Schlaepfer TE, Andersen HF, Kilts CD.
    J Psychiatr Res; 2009 Feb 03; 43(5):568-75. PubMed ID: 18954875
    [Abstract] [Full Text] [Related]

  • 20. Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial.
    Kornstein SG, Bose A, Li D, Saikali KG, Gandhi C.
    J Clin Psychiatry; 2006 Nov 03; 67(11):1767-75. PubMed ID: 17196058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.